Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

ClinicalTrials.gov ID: NCT03831880

Public ClinicalTrials.gov record NCT03831880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL, CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON) VERSUS DAILY GROWTH HORMONE (GENOTROPIN (REGISTERED)) INJECTIONS IN CHILDREN WITH GROWTH HORMONE DEFICIENCY

Study identification

NCT ID
NCT03831880
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
87 participants

Conditions and interventions

Interventions

  • Genotropin Drug
  • somatrogon Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 6, 2019
Primary completion
Aug 27, 2020
Completion
Aug 27, 2020
Last update posted
Oct 13, 2021

2019 – 2020

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Center of Excellence in Diabetes and Endocrinology Sacramento California 95821
Children's Hospital Colorado Aurora Colorado 80045
Rocky Mountain Pediatric Endocrinology Centennial Colorado 80112
Pediatric Endocrine Associates, PC Greenwood Village Colorado 80111
Nemours Children's Health System Jacksonville Florida 32207
Nemours Children's Specialty Care Jacksonville Florida 32207
Nemours Biomedical Research Orlando Florida 32827
Nemours Children's Hospital Orlando Florida 32827
Nemours Children's Clinic Pensacola Florida 32514
Shriners Hospitals for Children Tampa Florida 33612
Emory Children's Center Atlanta Georgia 30322
IU Health Pharmacy Indianapolis Indiana 46202
Riley Hospital for Children Indianapolis Indiana 46202
Children's Mercy Hospital and Clinics Kansas City Missouri 64111
Hackensack University Medical Center Hackensack New Jersey 07601
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224
MultiCare Health System - Mary Bridge Children's Health Center Tacoma Washington 98405
MultiCare Institute for Research & Innovation Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03831880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2021 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03831880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →